thank you for your comments. I do appreciate them. You might be right. However, I don’t believe that supply is a major consideration of the FDA with this generic. Nevertheless, we will see what real meaning this will all have soon enough.
Hikma making a go for it? Very few do manufacturer at risk, very few. Yet, in the case of Amarin, nothing is what it seems.
Be well my friend and enjoy your weekend as well.